INMODE’s Aesthetic Medical Equipment is Leading the Way Globally

Trending News 🌥️

INMODE LTD ($NASDAQ:INMD) is a leading provider of aesthetic medical equipment globally. The company is well known for its hands-free and minimally-invasive surgical products. As of this writing, INMD has 8 patented technologies, up from 7 in FY ’21. INMD’s products are used by some of the world’s leading surgeons and hospitals. The company’s products are backed by clinical data and have a strong track record of safety and efficacy.

INMD is constantly innovating to bring new and better products to market. INMD’s position as a market leader is due to its commitment to research and development, its strong intellectual property portfolio, and its focus on customer satisfaction. The company is always looking for ways to improve its products and increase its market share.

Share Price

On Wednesday, INMODE LTD stock opened at $33.2 and closed at $31.3, drop by 6.6% from prior closing price of 33.5. The company’s products are known for their quality, safety, and efficacy. The company has a strong commitment to research and development, and its products are backed by extensive clinical data. Live Quote…

About the Company

VI Analysis

INMODE LTD is a medical device company that produces minimally invasive aesthetic solutions. The company’s products are used for a variety of procedures, including body contouring, skin tightening, fat reduction, and facial rejuvenation. INMODE LTD has a strong competitive advantage in the medical device market due to its innovative products and cutting-edge technology. The company’s fundamentals reflect its long-term potential, and it is classified as a ‘gorilla’ company due to its stable and high revenue or earning growth. INMODE LTD is strong in asset and growth, and weak in dividend. However, the company has a high health score of 10/10 with regard to its cashflows and debt, and is capable of paying off debt and funding future operations. More…

VI Peers

The market for aesthetic medical device is highly competitive with InMode Ltd. facing competition from Cutera Inc., Viveve Medical Inc., and Apyx Medical Corp. All four companies offer a range of products that target different areas of the body and address different aesthetic concerns. InMode Ltd. has a strong portfolio of products that are backed by clinical data and have a proven track record of safety and efficacy. The company’s products are also available in a variety of price points to meet the needs of different consumers.

– Cutera Inc ($NASDAQ:CUTR)

Cutera Inc is a medical device company that provides aesthetic treatments to patients worldwide. Founded in 1998, Cutera is headquartered in Brisbane, California, and has a market cap of 931.59M as of 2022. The company’s Return on Equity is -111.73%. Cutera’s products are used by physicians and other healthcare professionals to treat conditions such as wrinkles, acne, vascular lesions, and unwanted hair. The company’s products include laser and light-based devices, intense pulsed light devices, and radiofrequency devices.

– Viveve Medical Inc ($NASDAQ:VIVE)

Viveve Medical Inc. is a medical technology company that focuses on the treatment of female intimate health conditions. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity, the condition where the vaginal walls become stretched and loose. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

Viveve Medical Inc has a market cap of 6.19M as of 2022. The company’s Return on Equity is -179.17%. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

– Apyx Medical Corp ($NASDAQ:APYX)

Apyx Medical Corp is a medical device company that develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Apyx Medical Corp has a market cap of 149.01M as of 2022, a Return on Equity of -22.62%. The company develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Summary

INMODE LTD is a medical device company that manufactures and sells aesthetic medical equipment. The company’s products are used by physicians and other professionals in the medical aesthetics industry for a variety of procedures, including body contouring, skin tightening, and wrinkle reduction. INMODE LTD’s products are based on its proprietary elos technology, which uses a combination of radio frequency and light energy to heat tissue and stimulate the production of collagen. The company’s products are cleared by the FDA for use in the United States and are CE-marked for use in the European Union.

INMODE LTD is headquartered in Caesarea, Israel. The company has offices in the United States, Germany, France, Italy, Spain, and the United Kingdom.